Reagents and comnsumables
Ended Awarded Last action
- Contract number
- 75N91021F00004
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $11,860
Award facts
- Contract value 100% obligated
- $11,860.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
- Legislative mandates
-
- Economy Act FAR subpart 17.5
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute issued a delivery order to Roche Diagnostics Corporation on May 10, 2021, for reagents and consumables for Ventana Medical Systems Benchmark Ultra immunostainers, with a ceiling value of $11,860.20 under firm fixed-price terms.
Place of performance is Castleton, IN. The order was completed on June 9, 2021. No set-aside was used.
Quick answers
Who was awarded contract 75N91021F00004?
75N91021F00004 was awarded to Roche Diagnostics Corporation by National Cancer Institute (National Institutes of Health) on May 10, 2021.
How much is contract 75N91021F00004 worth?
The government has obligated $11,860 on 75N91021F00004.
Is contract 75N91021F00004 an order under another contract?
Yes. 75N91021F00004 is a delivery order under 75N91019D00038, an indefinite delivery contract.
Was contract 75N91021F00004 competed?
The extent of competition for 75N91021F00004 was not competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award